Zobrazeno 1 - 10 of 22 pro vyhledávání: '"Yvette H, van Beurden"'
1
Akademický článek
Fecal microbiota composition is a better predictor of recurrent Clostridioides difficile infection than clinical factors in a prospective, multicentre cohort study
Autor: Tessel M. van Rossen, Yvette H. van Beurden, Johannes A. Bogaards, Andries E. Budding, Chris J.J. Mulder, Christina M.J.E. Vandenbroucke-Grauls
Publikováno v: BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Introduction Clostridioides difficile infection (CDI) is the most common cause of antibiotic-associated diarrhoea. Fidaxomicin and fecal microbiota transplantation (FMT) are effective, but expensive therapies to treat recurrent CDI (reCDI).
Externí odkaz: https://doaj.org/article/20cc540d62544c89b53c792927d296f9
Zobrazit plný text záznamu
2
Akademický článek
External validation of two prediction tools for patients at risk for recurrent infection
Autor: Tessel M. van Rossen, Laura J. van Dijk, Martijn W. Heymans, Olaf M. Dekkers, Christina M. J. E. Vandenbroucke-Grauls, Yvette H. van Beurden
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 14 (2021)
Background: One in four patients with primary Clostridioides difficile infection (CDI) develops recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode increases. Early identification of patients at risk for rCDI might hel
Externí odkaz: https://doaj.org/article/b6b523fda9be4adca8c09567e0fa1e31
Zobrazit plný text záznamu
3
Akademický článek
Current challenges in the treatment of severe infection: early treatment potential of fecal microbiota transplantation
Autor: Yvette H. van Beurden, Max Nieuwdorp, Pablo J. E. J. van de Berg, Chris J. J. Mulder, Abraham Goorhuis
Publikováno v: Therapeutic Advances in Gastroenterology, Vol 10 (2017)
Fecal microbiota transplantation (FMT) is a very effective treatment for recurrent Clostridium difficile infection (CDI). Less is known about the application of FMT as a curative treatment of severe or complicated CDI. In this review, we present and
Externí odkaz: https://doaj.org/article/798493c67dbe41a487d0b369e74704de
Zobrazit plný text záznamu
4
Akademický článek
An Outbreak of Clostridium difficile Ribotype 027 Associated with Length of Stay in the Intensive Care Unit and Use of Selective Decontamination of the Digestive Tract: A Case Control Study.
Autor: Yvette H van Beurden, Olaf M Dekkers, Marije K Bomers, Annie M Kaiser, Robin van Houdt, Cornelis W Knetsch, Armand R J Girbes, Chris J J Mulder, Christina M J E Vandenbroucke-Grauls
Publikováno v: PLoS ONE, Vol 11, Iss 8, p e0160778 (2016)
An outbreak of Clostridium difficile ribotype 027 infection (CDI) occurred at an university hospital, involving 19 departments. To determine what hospital-associated factors drove the outbreak of this particular strain we performed a case-control stu
Externí odkaz: https://doaj.org/article/02ae05dd4a1248b5bbd352fa659461a3
Zobrazit plný text záznamu
5
[Rectal lesions and liver lesions caused by syphilis]
Autor: Jelle L G, Haitsma Mulier, Yvette H, van Beurden, Brechje C, van Eijck, Wil A, van der Reijden, Steven F L, van Lelyveld
Publikováno v: Nederlands tijdschrift voor geneeskunde. 165
Syphilis is a sexually transmitted disease, caused by the spirochete Treponema Pallidum. Many different manifestations exist, which can complicate diagnosis.A 36-year-old man with a known HIV infection, presented himself with rectal blood loss and ab
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::52266cc20eef41d1f35f83da39f58561
https://pubmed.ncbi.nlm.nih.gov/34854615
Zobrazit plný text záznamu
6
Serial Microbiota Analysis after Fecal Microbiota Transplantation in a Child with Down's Syndrome
Autor: Clementien L. Vermont, Yvette H. van Beurden, Andries E. Budding, Tim G. J. de Meij, Lisethe Meijer, Chris J. J. Mulder
Publikováno v: Journal of pediatric infectious diseases, 14(3), 136-139. GEORG THIEME VERLAG KG
JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 14(3), 136-139. IOS Press
Beurden, Y H V, Meijer, L, Vermont, C L, Budding, A E, Mulder, C J J & Meij, T G D 2019, ' Serial Microbiota Analysis after Fecal Microbiota Transplantation in a Child with Down's Syndrome ', JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, vol. 14, no. 3, pp. 136-139 . https://doi.org/10.1055/s-0037-1606330
Fecal microbiota transplantation (FMT) is a very effective treatment for recurrent Clostridium difficile infection (CDI) in adults. However, there is a paucity of data on FMT in children and associated microbiome changes in this particular group. We
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b37c1a541394172f2435e8423b9a44bd
https://doi.org/10.1055/s-0037-1606330
Zobrazit plný text záznamu
7
External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection
Autor: Yvette H. van Beurden, Christina M. J. E. Vandenbroucke-Grauls, Olaf M. Dekkers, Laura J. van Dijk, Tessel M. van Rossen, Martijn W. Heymans
Publikováno v: Therapeutic Advances in Gastroenterology, 14. SAGE Publications Ltd
Therapeutic Advances in Gastroenterology, 14, 1-15. SAGE PUBLICATIONS LTD
van Rossen, T M, van Dijk, L J, Heymans, M W, Dekkers, O M, Vandenbroucke-Grauls, C M J E & van Beurden, Y H 2021, ' External validation of two prediction tools for patients at risk for recurrent Clostridioides difficile infection ', Therapeutic Advances in Gastroenterology, vol. 14 . https://doi.org/10.1177/1756284820977385
Background: One in four patients with primary Clostridioides difficile infection (CDI) develops recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode increases. Early identification of patients at risk for rCDI might hel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ba870ac2cdafc00701201553625d93
https://research.vumc.nl/en/publications/a6847e05-f65e-485e-acc3-54f932bccb96
Zobrazit plný text záznamu
8
Faecal microbiota transplantation for Clostridioides difficile infection:Four years’ experience of the Netherlands Donor Feces Bank
Autor: Abraham Goorhuis, Elisabeth M. Terveer, Rogier E. Ooijevaar, Ed J. Kuijper, Josbert J. Keller, Hein W. Verspaget, Joffrey van Prehn, Marcel G. W. Dijkgraaf, Emilie van Lingen, Yvette H. van Beurden, Jos F.M.L. Seegers, Christina M. J. E. Vandenbroucke-Grauls, Chris J. J. Mulder, Karuna E. W. Vendrik, Els van Nood, Martijn P. Bauer, Eline Boeije-Koppenol
Publikováno v: Terveer, E M, Vendrik, K E W, Ooijevaar, R E, Lingen, E V, Boeije-Koppenol, E, Nood, E V, Goorhuis, A, Bauer, M P, van Beurden, Y H, Dijkgraaf, M G W, Mulder, C J J, Vandenbroucke-Grauls, C M J E, Seegers, J F M L, van Prehn, J, Verspaget, H W, Kuijper, E J & Keller, J J 2020, ' Faecal microbiota transplantation for Clostridioides difficile infection : Four years’ experience of the Netherlands Donor Feces Bank ', United European Gastroenterology Journal, vol. 8, no. 10, pp. 1236-1247 . https://doi.org/10.1177/2050640620957765
United European gastroenterology journal, 8(10), 1236-1247. SAGE Publications Inc.
United European Gastroenterology Journal, 8(10), 1236-1247. SAGE Publications Inc.
United European Gastroenterology Journal, 8(10), 1236-1247. SAGE Publishing
United European Gastroenterology Journal
United European Gastroenterology Journal, 8(10), 1236-1247. SAGE PUBLICATIONS INC
Background: The Netherlands Donor Feces Bank provides standardized ready-to-use donor faecal suspensions for faecal microbiota transplantation treatment of patients with recurrent Clostridioides difficile infection. Objective: The purpose of this stu
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8701d79f7d3dc2e7417bca179e12559c
https://research.vumc.nl/en/publications/cd594fcb-c5f2-4699-a497-3245ae8a6b84
Zobrazit plný text záznamu
9
External validation of two prediction tools for patients at risk for recurrent
Autor: Tessel M, van Rossen, Laura J, van Dijk, Martijn W, Heymans, Olaf M, Dekkers, Christina M J E, Vandenbroucke-Grauls, Yvette H, van Beurden
Publikováno v: Therapeutic Advances in Gastroenterology
Background: One in four patients with primary Clostridioides difficile infection (CDI) develops recurrent CDI (rCDI). With every recurrence, the chance of a subsequent CDI episode increases. Early identification of patients at risk for rCDI might hel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1fc5a4a871e21637c1a689de4284198f
https://pubmed.ncbi.nlm.nih.gov/33456500
Zobrazit plný text záznamu
10
Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection
Autor: Els van Nood, Josbert J. Keller, Abraham Goorhuis, Max Nieuwdorp, Pieter F. de Groot, Yvette H. van Beurden
Publikováno v: United European Gastroenterology Journal, 5(6), 868-879. SAGE Publications Inc.
United European gastroenterology journal, 5(6), 868-879. SAGE Publications Inc.
United European Gastroenterology Journal, 5(6), 868-879. SAGE Publishing
van Beurden, Y H, de Groot, P F, van Nood, E, Nieuwdorp, M, Keller, J J & Goorhuis, A 2017, ' Complications, effectiveness, and long term follow-up of fecal microbiota transfer by nasoduodenal tube for treatment of recurrent Clostridium difficile infection ', United European Gastroenterology Journal, vol. 5, no. 6, pp. 868-879 . https://doi.org/10.1177/2050640616678099
BACKGROUND: Fecal microbiota transfer (FMT) is an effective treatment for recurrent Clostridium difficile infection (CDI), but data on procedure-related complications and long-term outcome are scarce.METHODS: All patients treated with FMT for recurre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d45fe2fd69071022a1a9449fd98c49c
https://research.vumc.nl/en/publications/52008934-a6d4-4ff2-92ef-5587f7fdd1a4
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje